As director of corporate venture capital at Sekisui America Corporation, Carothers will help build, evolve and lead Sekisui Chemical’s global corporate venturing platform.

Cassandra Carothers has joined Sekisui America Corporation as director of corporate venture capital to help build, evolve and lead Sekisui Chemical’s global corporate venturing platform.
Her role will involve investing globally in strategically aligned opportunities across advanced materials, aerospace, next-generation mobility, advanced manufacturing, robotics, energy infrastructure, life sciences, industrial technology and more, while prioritising new business creation and social impact.
Carothers was previously managing director at Departure Capital, a VC fund investing in frontier technologies, for over four years. Prior to that, she held investment roles at VC firms Upheaval Investments, Millennium New Horizons, Bay Bridge Ventures and Spock Ventures, where she gained experience in fund formation, fundraising, diligence and portfolio management.
Speaking of her transition to corporate venturing in the LinkedIn post announcing her new role, Carothers said: “One of the reasons I most look forward to taking a corporate perspective on this industry is that CVC has a unique opportunity to add value beyond capital, providing some of the most critical commercialization infrastructure that can move the needle for innovators, ranging from access to customers and market knowledge, to supply chains and regulatory relationships.”
Sekisui America Corporation is the North America regional headquarters of Japan-based Sekisui Chemical. Comprised of 10 companies, SAC is focused on providing solutions that help people overcome today’s challenges while fuelling the world for a better tomorrow.

Our annual industry survey tracks metrics such as fund and team size, salary and performance across the corporate venture sector globally.
Add your data and receive a free copy of the resulting benchmarking report. All data is anonymised.
